7,078
Views
5
CrossRef citations to date
0
Altmetric
Articles

Probiotics for cure of Helicobacter pylori infection: A review

, , , &
Pages 2215-2222 | Received 19 Jun 2016, Accepted 03 Sep 2016, Published online: 28 Jan 2017

References

  • Saulnier, N.; Zocco, M.A.; Di Caro, S.; Gasbarrini, G.; Gasbarrini, A. Probiotics and Small Bowel Mucosa: Molecular Aspects of their Interactions. Genes Nutrition 2006, 1(2), 107–115.
  • Rokka, S.; Myllykangas, S.; Joutsjoki, V. Effect of Specific Colostral Antibodies and Selected Lactobacilli on the Adhesion of Helicobacter pylori on AGS Cells and the Helicobacter-Induced IL-8 Production. Scandinavian Journal of Immunology 2008, 68(3), 280–286.
  • Patel, A.; Shah, N.; Prajapati, J.B. Clinical Application of Probiotics in the Treatment of Helicobacter Pylori Infection—A Brief Review. Journal of Microbiology, Immunology and Infection 2014, 47(5), 429–437.
  • Nista, E.C.; et al. Bacillus Clausii Therapy to Reduce Side-Effects of Anti-Helicobacter pylori Treatment: Randomized, Double-Blind, Placebo Controlled Trial. Alimentary Pharmacology and Therapeutics 2004, 20(10), 1181–1188.
  • Ziemniak, W. Efficacy of Helicobacter pylori Eradication Taking into Account its Resistance to Antibiotics. Journal of Physiology and Pharmacology 2006, 57(Suppl 3), 123–141.
  • Egan, B.J.; et al. Treatment of Helicobacter pylori. Helicobacter 2007, 12(Suppl 1), 31–37.
  • Scaccianoce, G.; et al. Triple Therapies Plus Different Probiotics for Helicobacter pylori Eradication. European Review for Medical and Pharmacological Sciences 2008, 12(4), 251–256.
  • Drouin, E. Helicobacter pylori: Novel Therapies. Candian Journal of Gastroenterology 1999, 13(7), 581–583.
  • Efrati, C.; et al. Helicobacter pylori Eradication: Sequential Therapy and Lactobacillus reuteri Supplementation. World Journal of Gastroenterology: WJG 2012, 18(43), 6250–6254.
  • Lionetti, E.; et al. Probiotics and Helicobacter pylori Infection in Children. Journal of Biological Regulators and Homeostatic Agents 2012, 26(1 Suppl), S69–S76.
  • Roma, E.; Miele, E. Helicobacter pylori Infection in Pediatrics. Helicobacter 2015, 20(S1), 47–53.
  • Malfertheiner, P.; et al. Current Concepts in the Management of Helicobacter pylori Infection: The Maastricht III Consensus Report. Gut 2007, 56(6), 772–781.
  • Dore, M.P.; et al. Lactobacillus reuteri in the Treatment of Helicobacter pylori Infection. Internal and Emergency Medicine 2014, 9(6), 649–654.
  • Ahmad, K.; et al. Probiotics for the Treatment of Pediatric helicobacter pylori Infection: A Randomized Double Blind Clinical Trial. Iranian Journal of Pediatrics 2013, 23(1), 79–84.
  • O’Connor, A.; et al. Treatment of Helicobacter pylori Infection 2013. Helicobacter 2013, 18(Suppl 1), 58–65.
  • Dajani, A.I.; et al. Do Probiotics Improve Eradication Response to Helicobacter pylori on Standard Triple or Sequential Therapy? Saudi Journal of Gastroenterology 2013, 19(3), 113–120.
  • Hamilton-Miller, J.M. The Role of Probiotics in the Treatment and Prevention of Helicobacter pylori Infection. International Journal of Antimicrobial Agents 2003, 22(4), 360–366.
  • Tursi, A.; et al. Effect of Lactobacillus Casei Supplementation on the Effectiveness and Tolerability of a New Second-Line 10-Day Quadruple Therapy after Failure of a First Attempt to Cure Helicobacter pylori Infection. Medical Science Monitor 2004, 10(12), CR662–CR666.
  • Verdu, E.F.; et al. The Role of Luminal Factors in the Recovery of Gastric Function and Behavioral Changes after Chronic Helicobacter pylori Infection. American Journal of Physiology, Gastrointestinal and Liver Physiology 2008, 295(4), G664–G670.
  • Zhang, M.-M.; et al. Probiotics in Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-Analysis. World Journal of Gastroenterology: WJG 2015, 21(14), 4345.
  • Mehling, H.; Busjahn, A. Non-Viable Lactobacillus Reuteri DSMZ 17648 (Pylopass) as a New Approach to Helicobacter Pylori Control in Humans. Nutrients 2013, 5(8), 3062–3073.
  • Lesbros-Pantoflickova, D.; Corthesy-Theulaz, I.; Blum, A.L. Helicobacter pylori and Probiotics. Journal of Nutrition 2007, 137(3Suppl 2), 812S–818S.
  • Blaser, M.J. Helicobacters are Indigenous to the Human Stomach: Duodenal Ulceration is Due to Changes in Gastric Microecology in the Modern Era. Gut 1998, 43(5), 721–727.
  • Kim, J.M.; et al. Conjugated Linoleic Acids Produced by Lactobacillus Dissociates IKK-[Gamma] and Hsp90 Complex in Helicobacter pylori-Infected Gastric Epithelial Cells. Labortary Investigation 2008, 88(5), 541–552.
  • Bercik, P.; et al. Immune-Mediated Neural Dysfunction in a Murine Model of Chronic Helicobacter pylori Infection. Gastroenterology 2002, 123(4), 1205–1215.
  • Fuller, R. Probiotics in Human Medicine. Gut 1991, 32(4), 439–442.
  • Hungin, A.P.; et al. Systematic Review: Probiotics in the Management of Lower Gastrointestinal Symptoms in Clinical Practice – An Evidence-Based International Guide. Alimentary Pharmacology and Therapeutics 2013, 38(8), 864–886.
  • Hutt, P.; et al. Antagonistic Activity of Probiotic Lactobacilli and Bifidobacteria against Entero- and Uropathogens. Journal of Applied Microbiology 2006, 100(6), 1324–1332.
  • Johnson-Henry, K.C.; et al. Probiotics Reduce Bacterial Colonization and Gastric Inflammation in H. pylori-Infected Mice. Digestive Diseases and Sciences 2004, 49(7–8), 1095–1102.
  • Butel, M.-J. Probiotics, Gut Microbiota and Health. Médecine et maladies infectieuses 2014, 44(1), 1–8.
  • Jarosz, M.; et al. Dietary and Socio-Economic Factors in Relation to Helicobacter pylori Re-Infection. World Journal of Gastroenterology: WJG 2009, 15(9), 1119–1125.
  • Thomas, D.W.; et al. Probiotics and Prebiotics in Pediatrics. Pediatrics 2010, 126(6), 1217–1231.
  • Burns, A.J.; Rowland, I.R. Anti-Carcinogenicity of Probiotics and Prebiotics. Current Issues of Intestinal Microbiology 2000, 1(1), 13–24.
  • de Vrese, M.; Schrezenmeir, J. Probiotics, Prebiotics, and Synbiotics. Advancs in Biochemical Engoineering/Biotechnology 2008, 111, 1–66.
  • Gupta, V.; Garg, R. Probiotics. Indian Journal of Medical Microbiology 2009, 27(3), 202–209.
  • Caramia, G. Metchnikoff and the Centenary of Probiotics: An Update of their Use in Gastroenteric Pathology during the Age of Development. Minerva Pediatrica 2008, 60(6), 1417–1435.
  • Videlock, E.J.; Cremonini, F. Meta-Analysis: Probiotics in Antibiotic-Associated Diarrhoea. Alimentary Pharmacology and Therapeutics 2012, 35(12), 1355–1369.
  • Buzas, G.M. [Probiotics in Gastroenterology – From a Different Angle]. Orvosi Hetilap 2013, 154(8), 294–304.
  • Zheng, X.; Lyu, L.; Mei, Z. Lactobacillus-Containing Probiotic Supplementation Increases Helicobacter pylori Eradication Rate: Evidence from a Meta-Analysis. Revista Espanola de Enfermdades Digestivas 2013, 105(8), 445–453.
  • Tong, J.L.; et al. Meta-Analysis: The Effect of Supplementation with Probiotics on Eradication Rates and Adverse Events during Helicobacter pylori Eradication Therapy. Alimentary Pharmacology and Therapeutics 2007, 25(2), 155–168.
  • Wang, Z.H.; Gao, Q.Y.; Fang, J.Y. Meta-Analysis of the Efficacy and Safety of Lactobacillus-Containing and Bifidobacterium-Containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy. Journal of Clinical Gastroenterology 2013, 47(1), 25–32.
  • Sachdeva, A.; Nagpal, J. Meta-Analysis: Efficacy of Bovine Lactoferrin in Helicobacter pylori Eradication. Alimentary Pharmacology and Therapeutics 2009, 29(7), 720–730.
  • Zou, J.; Dong, J.; Yu, X.F. Meta-Analysis: The Effect of Supplementation with Lactoferrin on Eradication Rates and Adverse Events During Helicobacter pylori Eradication Therapy. Helicobacter 2009, 14(2), 119–127.
  • Sachdeva, A.; Nagpal, J. Effect of Fermented Milk-Based Probiotic Preparations on Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials. European Journal of Gastroenterology and Hepatology 2009, 21(1), 45–53.
  • Molina-Infante, J.; Gisbert, J.P. Probiotics for Helicobacter pylori Eradication Therapy: Not Ready for Prime Time. Revista Espanola de Enfermdades Digestivas 2013, 105(8), 441–444.
  • Li, S.; et al. Meta-analysis of Randomized Controlled Trials on the Efficacy of Probiotics in Helicobacter pylori Eradication Therapy in Children. European Journal of Pediatrics 2014, 173(2), 153–161.
  • de Bortoli, N.; et al. Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy Versus Triple Therapy Plus Lactoferrin and Probiotics. The American Journal of Gastroenterology 2007, 102(5), 951–956.
  • Szajewska, H.; Horvath, A.; Piwowarczyk, A. Meta-Analysis: The Effects of Saccharomyces boulardii Supplementation on Helicobacter pylori Eradication Rates and Side Effects During Treatment. Alimentary Pharmacology and Therapeutics 2010, 32(9), 1069–1079.
  • Pacifico, L.; et al. Probiotics for the Treatment of Helicobacter pylori Infection in Children. World Journal of Gastroenterology: WJG 2014, 20(3), 673–683.
  • Pongpech, P.; Hentges, D.J. Inhibition of Shigella sonnei and Enterotoxigenic Escherichia coli by Volatile Fatty Acids in Mice. Microbial Ecology in Health and Disease 1989, 2(3), 153–161.
  • Collado, M.C.; Hernandez, M.; Sanz, Y. Production of Bacteriocin-Like Inhibitory Compounds by Human Fecal Bifidobacterium Strains. Journal of Food Protection 2005, 68(5), 1034–1040.
  • Myllyluoma, E.; et al. Effects of Multispecies Probiotic Combination on helicobacter pylori Infection In Vitro. Clinical and Vaccine Immunology 2008, 15(9), 1472–1482.
  • Rieder, G.; et al. Role of Adherence in Interleukin-8 Induction in Helicobacter pylori-Associated Gastritis. Infection and Immununity 1997, 65(9), 3622–3630.
  • Garcia, C.A.; et al. [Probiotic Properties of Lactobacillus spp Isolated from Gastric Biopsies of Helicobacter pylori Infected and Non-Infected Individuals]. Revista Medica de Chile 2009, 137(3), 369–376.
  • Mack, D.R.; et al. Probiotics Inhibit Enteropathogenic E. coli Adherence In Vitro by Inducing Intestinal Mucin Gene Expression. American Journal of Physiology 1999, 276(4 Pt 1), G941–G950.
  • Yang, Y.J.; et al. Lactobacillus acidophilus Ameliorates H. pylori-Induced Gastric Inflammation by Inactivating the Smad7 and NFkappaB Pathways. BMC Microbiology 2012, 12, 38.
  • Pena, J.A.; Versalovic, J.; Lactobacillus Rhamnosus GG Decreases TNF-Alpha Production in Lipopolysaccharide-Activated Murine Macrophages by a Contact-Independent Mechanism. Cell Microbiology 2003, 5(4), 277–285.
  • Gill, H.S. Probiotics to Enhance Anti-Infective Defences in the Gastrointestinal Tract. Best Practice and Research Clinical Gastroenterolgy 2003, 17(5), 755–773.
  • Haller, D.; et al. Non-Pathogenic Bacteria Elicit a Differential Cytokine Response by Intestinal Epithelial Cell/Leucocyte Co-Cultures. Gut 2000, 47(1), 79–87.
  • Li, S.; et al. Meta-analysis of Randomized Controlled Trials on the Efficacy of Probiotics in Helicobacter pylori Eradication Therapy in Children. European Journal of Pediatrics 2014, 173(2), 153–161.
  • Adams, C.A. The Probiotic Paradox: Live and Dead Cells are Biological Response Modifiers. Nutrition Research Reviews 2010, 23(1), 37–46.
  • Tolone, S.; et al. Evaluation of Helicobacter Pylori Eradication in Pediatric Patients by Triple Therapy Plus Lactoferrin and Probiotics Compared to Triple Therapy Alone. Italian Journal of Pediatrics 2012, 38, 63.
  • D’Souza, A.L.; Rajkumar, C.; Cooke, J.; Bulpitt, C.J. Probiotics in Prevention of Antibiotic Associated Diarrhoea: Meta-Analysis. BMJ 2002, 324, 1361.
  • Isobe, H.; et al. Reduction of Overall Helicobacter pylori Colonization Levels in the Stomach of Mongolian Gerbil by Lactobacillus Johnsonii La1 (LC1) and its In Vitro Activities against H. pylori Motility and Adherence. Bioscience Biotechnology Biochemistry 2012, 76(4), 850–852.
  • Allen, S.J.; Okoko, B.; Martínez, E.; Gregorio, G.; Dans, L.F. Probiotics for Treating Infectious Diarrhoea (Cochrane Review). In: The Cochrane Library, issue 4, 2003 [online]. Available at http://www.update-software.com/abstracts/AB000333.htm.
  • Kalliomaki, M.; et al. Probiotics and Prevention of Atopic Disease: 4-Year Follow-Up of a Randomised Placebo-Controlled Trial. Lancet 2003, 361(9372), 1869–1871.
  • Sykora, J.; et al. Effects of a Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus Casei DN-114 001 and the Eradication of H. pylori in Children: A Prospective Randomized Double-Blind Study. Journal of Clinical Gastroenterology 2005, 39(8), 692–698.
  • Weng, M.; Walker, W.A. Bacterial Colonization, Probiotics, and Clinical Disease. The Journal of Pediatrics 2006, 149(5), S107–S114.
  • Mallon, P.; McKay, D.; Kirk, S.; Gardiner K. Probiotics for Induction of Remission in Ulcerative Colitis. Cochrane Database Systematic Reviews 2007, 17(4), CD005573.
  • Shen, J.; Zuo, Z.X.; Mao, A.P. Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn’s Disease, and Pouchitis: Meta-Analysis of Randomized Controlled Trials. Inflammatory Bowel Diseases 2014, 20(1), 21–35.
  • Schultz, M.; et al. Lactobacillus GG in Inducing and Maintaining Remission of Crohn’s Disease. BMC Gastroenterology 2004, 4, 5.
  • Kim, H.J.; et al. Clinical Efficacy and Mechanism of Probiotics in Allergic Diseases. Korean Journal of Pediatrics 2013, 56(9), 369–376.
  • O’Mahony, L.; et al. Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome: Symptom Responses and Relationship to Cytokine Profiles. Gastroenterology 2005, 128(3), 541–551.
  • van der Aa, L.B.; et al. Probiotics and Prebiotics in Atopic Dermatitis: Review of the Theoretical Background and Clinical Evidence. Pediatric Allergy and Immunology 2010, 21(2 Pt 2), e355–e367.
  • Narayan, S.S.; et al. Probiotics: Current Trends in the Treatment of Diarrhoea. Hong Kong Medical Journal 2010, 16(3), 213–218.
  • Kim, J.Y.; et al. Lipoteichoic Acid Isolated from Lactobacillus plantarum Suppresses LPS-Mediated Atherosclerotic Plaque Inflammation. Molecular Cells 2013, 35(2), 115–124.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.